|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.33 USD | -3.70% |
|
-5.54% | +23.12% |
| 07-29 | Wedbush Adjusts Damora Therapeutics Price Target to $40 From $35, Maintains Outperform Rating | MT |
| 07-27 | Jefferies Initiates Coverage on Damora Therapeutics With Buy Rating, $50 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 32.99 | 32.99 | 34.14 |
| Spread/Res. | -14.13% | -14.13% | -17.02% |
| Spread/Supp. | +2.91% | +9.42% | +123.78% |
| Support | 27.53 | 25.89 | 12.66 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DMRA Stock
- Charts Damora Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
